A Rare Case of Acute Generalized Exanthematous Pustulosis with Drug-Induced Liver Injury caused by Pyrazinamide

1. Thienvibul C, Vachiramon V, Chanprapaph K. Five-year retrospective review of acute generalized exant hematous pustulosis. Dermatol Res Pract. 2015;2015:260928.10.1155/2015/260928468998226783390Search in Google Scholar

2. Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): a review and update. J Am Acad Dermatol. 2015;73(5):843-8.10.1016/j.jaad.2015.07.01726354880Search in Google Scholar

3. Trapp K. Acute generalized exanthematous pustulosis: AGEP. In: Crowe DR, Morgan M, Somach S, Trapp K. DDV. Cham: Springer; 2016. p. 173-5.10.1007/978-3-319-31566-9_28Search in Google Scholar

4. Feldmeyer L, Heidemeyer K, Yawalkar N. Acute generalized exanthematous pustulosis: pathogenesis, genetic background, clinical variants and therapy. Int J Mol Sci. 2016;17(8):1214.10.3390/ijms17081214500061227472323Search in Google Scholar

5. Heelan K, Sibbald C, Shear N. Cutaneous reactions to drugs. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al. Fitzpatrick’s dermatology. 9th ed. New York: Mc Graw Hill Education; 2019. p. 751.Search in Google Scholar

6. Hotz C, Valeyrie-Allanore L, Haddad C, Bouvresse S, Ortonne N, Duong T, et al. Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients. Br J Dermatol. 2013;169(6):1223-32.10.1111/bjd.1250223855377Search in Google Scholar

7. Lu RJ, Zhang Y, Tang F, Zheng ZW, Fan ZD, Zhu SM, et al. Clinical characteristics of drug-induced liver injur y and related risk factors. E xp Ther Med. 2016;12(4):2606-16.10.3892/etm.2016.3627503886727703513Search in Google Scholar

8. Giordano C, Rivas J, Zervos X. An update on treatment of drug-induced liver injury. J Clin Transl Hepatol. 2014;2(2):74-9.Search in Google Scholar

9. Shih TY, Pai CY, Yang P, Chang WL, Wang NC, Hu OY. A novel mechanism underlies the hepatotoxicity of pyra zinamide. Antimicrob Agents Chemother. 2013;57(4):1685-90.10.1128/AAC.01866-12362334423357778Search in Google Scholar

10. Sánchez-Borges M, Thong B, Blanca M, Ensina LF, González-Díaz S, Greenberger PA, et al. Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy. World Allergy Organ J. 2013;6(1):18.10.1186/1939-4551-6-18444664324175948Search in Google Scholar

11. Lockwood S, Saavedra A. Cutaneous reactions to drugs. In: Khan DA, Banerji A. Drug allergy testing. St. Louis: Elsevier; 2018. p. 53-72.10.1016/B978-0-323-48551-7.00006-7Search in Google Scholar

12. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: drug-induced liver injury. J Hepatol. 2019;70(6):1222-61.10.1016/j.jhep.2019.02.01430926241Search in Google Scholar

13. Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174(8):935-52.10.1164/rccm.200510-1666ST17021358Search in Google Scholar